In this study, we observed that APOE4 carriers with low amounts of AD neuropathology at death had decreased mortality risk compared to non-carriers, but APOE4 carriers with high amounts of AD neuropathology at death had increased mortality risk. The gene discussed is APOE; the disease is Alzheimer disease.